Literature DB >> 16764698

FOXP3 identifies regulatory CD25bright CD4+ T cells in rheumatic joints.

D Cao1, O Börjesson, P Larsson, A Rudin, I Gunnarsson, L Klareskog, V Malmström, C Trollmo.   

Abstract

Regulatory T cells have recently been implicated in a number of human diseases, including rheumatoid arthritis. To investigate whether the presence of CD25+CD4+ regulatory T cells is a general finding in arthritic joints, synovial fluid of patients with different rheumatic diseases such as undifferentiated arthritides, systemic rheumatic diseases and reactive arthritis were investigated for the presence of such cells. In 95% of the patients, a higher frequency of CD25(bright)CD4+ T cells was found in synovial fluid as compared with peripheral blood. Both in vitro suppression experiments and FOXP3 mRNA analysis confirmed these cells to be natural regulatory T cells. Together with our previous data, we conclude that arthritic joints, irrespective of precise diagnosis and disease duration, are enriched with natural regulatory T cells. These results suggest that suppressor cells migrate to and/or multiply at the sites of inflammation as part of the immune responses' effort to combat injurious inflammation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16764698     DOI: 10.1111/j.1365-3083.2006.001755.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  23 in total

1.  Treg cell numbers and function in patients with antibiotic-refractory or antibiotic-responsive Lyme arthritis.

Authors:  Shiqian Shen; Junghee J Shin; Klemen Strle; Gail McHugh; Xin Li; Lisa J Glickstein; Elise E Drouin; Allen C Steere
Journal:  Arthritis Rheum       Date:  2010-07

Review 2.  Regulatory T cells in rheumatoid arthritis.

Authors:  Sujata Sarkar; David A Fox
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

3.  Aberrant TGF-β1 signaling contributes to the development of primary biliary cirrhosis in murine model.

Authors:  Bin Liu; Xuan Zhang; Feng-Chun Zhang; Jin-Bao Zong; Wen Zhang; Yan Zhao
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

4.  Impaired balance of T helper 17/T regulatory cells in carbon tetrachloride-induced liver fibrosis in mice.

Authors:  Xiao-Fei Sun; Lei Gu; Wen-Sheng Deng; Qing Xu
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

5.  Transient regulatory T-cells: a state attained by all activated human T-cells.

Authors:  Vinodh Pillai; Sterling B Ortega; C K Wang; Nitin J Karandikar
Journal:  Clin Immunol       Date:  2006-12-19       Impact factor: 3.969

6.  Requirement for diverse TCR specificities determines regulatory T cell activity in a mouse model of autoimmune arthritis.

Authors:  Soyoung Oh; Malinda Aitken; Donald M Simons; Alissa Basehoar; Victoria Garcia; Elizabeth Kropf; Andrew J Caton
Journal:  J Immunol       Date:  2012-03-26       Impact factor: 5.422

Review 7.  Functional Defects of Treg Cells: New Targets in Rheumatic Diseases, Including Ankylosing Spondylitis.

Authors:  Jinlin Miao; Ping Zhu
Journal:  Curr Rheumatol Rep       Date:  2018-04-16       Impact factor: 4.592

8.  Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation.

Authors:  Thomas Korn; Jayagopala Reddy; Wenda Gao; Estelle Bettelli; Amit Awasthi; Troels R Petersen; B Thomas Bäckström; Raymond A Sobel; Kai W Wucherpfennig; Terry B Strom; Mohamed Oukka; Vijay K Kuchroo
Journal:  Nat Med       Date:  2007-03-25       Impact factor: 53.440

Review 9.  The dynamics of effector T cells and Foxp3+ regulatory T cells in the promotion and regulation of autoimmune encephalomyelitis.

Authors:  Thomas Korn; Ana C Anderson; Estelle Bettelli; Mohamed Oukka
Journal:  J Neuroimmunol       Date:  2007-10-03       Impact factor: 3.478

10.  Increased number and function of FoxP3 regulatory T cells during experimental arthritis.

Authors:  Kristen Monte; Christina Wilson; Fei F Shih
Journal:  Arthritis Rheum       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.